Publication | Closed Access

Silibinin alleviates high glucose-suppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3K/Akt signaling

SclerostinAntioxidant EffectBone Morphogenic ProteinMedicineOsteoporosisPharmacologyCell BiologyCell SignalingBone MetabolismOxidative Stress